Evidence map›Paper›PMID 40661879›Full record

ArticleOpen forum infectious diseases2025

Achieving Greater Transparency Regarding Molecular HIV Surveillance: A Proposal to Move Beyond the Status Quo.

Caroline Lumpkins, Gail Geller, Travis Sanchez, Janesse Brewer, Juli Bollinger, S Mandisa Moore-O'Neal, Coralei Neighbors, Carlos Saldana, Jeremy Sugarman

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Caroline LumpkinsBerman Institute of Bioethics, Johns Hopkins University, Baltimore, Maryland, USA.
Gail GellerBerman Institute of Bioethics, Johns Hopkins University, Baltimore, Maryland, USA.
Travis SanchezDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
Janesse BrewerDepartment of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.
Juli BollingerBerman Institute of Bioethics, Johns Hopkins University, Baltimore, Maryland, USA.ORCID https://orcid.org/0000-0001-6850-8562
S Mandisa Moore-O'NealThe Center for HIV Law and Policy, Brooklyn, New York, USA.
Coralei NeighborsDepartment of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA.ORCID https://orcid.org/0000-0002-0367-2983
Carlos SaldanaDepartment of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA.
Jeremy SugarmanBerman Institute of Bioethics, Johns Hopkins University, Baltimore, Maryland, USA.ORCID https://orcid.org/0000-0001-7022-8332

Funding

Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
NIAID NIH HHS P30 AI050409
6 · The paper itself

Abstract

Molecular HIV surveillance is used to in effort to enhance HIV prevention efforts by identifying emerging clusters of rapid HIV transmission. In the United States, it relies upon data from antiretroviral resistance testing done in the context of clinical care. However, information about the public health uses of these data are not always disclosed to patients at the time of testing, which raises ethical concerns. Building upon accumulating data about this practice, a multidisciplinary group argues that there is a need to increase transparency of the practice through active disclosure.

Indexed as

consentdisclosuremolecular HIV surveillancetransparencytrust

Identifiers

PMID40661879
PMCPMC12256975

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.